Journal of Mycology and Infection

The Korean Society for Medical Mycology (대한의진균학회)
권호 표지
DOI QR코드

DOI QR Code

In vitro Susceptibility of the Six Malassezia Species to Itraconazole, Fluconazole and Terbinafine

말라세지아 균주 6종에 대한 항진균제 시험관내 감수성 시험

  • Lee, Yangwon (Department of Dermatology, Konkuk University School of Medicine)
  • 이양원 (건국대학교 의학전문대학원 피부과학교실)
  • Received : 2017.02.09
  • Accepted : 2017.03.09
  • Published : 2017.03.31
⟨ Previous Next ⟩

Abstract

Background: Malasseiza species are dimorphic and lipophilic fungi which are part of normal mycota of the human skin, and also associated with some skin diseases. In many skin diseases such as pityriasis versicolor, Malassezia folliculitis, seborrheic dermatitis, atopic dermatitis and psoriasis, Malassezia yeasts may have a key role. Objective: To investigate susceptibility of antifungal agent including itraconazole, fluconazole and terbinafine, we conducted in vitro susceptibility test revealing minimum inhibitory concentration of drugs for each Malassezia strains. Methods: Malassezia restricta CBS7877, M. globosa CBS 7966, M. slooffiae KCTC 27517, M. sympodialis CBS 7222, M. pachydermatis CBS 1879 and M. furfur CBS 1878 were used in this experiment. The strains were grown in Leeming and Notman medium. MIC was determined using the method suggested by Sugita, et al. with modification. Malassezia cells were grown in each well and incubated for 2 days at $34^{\circ}C$, and MIC was determined by agar dilution method. Results: Most Malasseiza strains of all Malassezia species were most sensitive to itraconazole, with MICs ranging from 0.015 to $0.06{\mu}g/mL$. MIC values of fluconazole and terbinafine against Malassezia species were higher and wider range than MIC of itraconazole. Conclusion: Itracozanole would be the first choice drug for treatment of Malassezia associated skin diseases. Isolation of pathologic species of Malassezia from various skin diseases in Korea would be fundamental research for the target therapy, and drug susceptibility test would be helpful for proper treatment.

Keywords

Acknowledgement

Supported by : 건국대학교

References

  1. Saunders CW, Scheynius A, Heitman J. Malassezia fungi are specialized to live on skin and associated with dandruff, eczema, and other skin diseases. Plos Pathog 2012;8:e1002701 https://doi.org/10.1371/journal.ppat.1002701
  2. Gao Z, Perez-Perez GI, Chen Y, Blaser MJ. Quantitation of major human cutaneous bacterial and fungal populations. J Clin Microbiol 2010;48:3575-3581 https://doi.org/10.1128/JCM.00597-10
  3. Cabanes FJ. Malassezia yeasts: how many species infect humans and animals? Plos Pathog 2014;10:e1003892 https://doi.org/10.1371/journal.ppat.1003892
  4. Prohic A, Jovovic Sadikovic T, Krupalija-Fazlic M, Kuskunovic-Vlahovljak S. Malassezia species in healthy skin and in dermatological conditions. Int J Dermatol 2016;55:494-504 https://doi.org/10.1111/ijd.13116
  5. Fry L, Baker BS, Powles AV, Fahlen A, Engstrand L. Is chronic plaque psoriasis triggered by microbiota in the skin? Brit J Dermatol 2013;169:47-52 https://doi.org/10.1111/bjd.12322
  6. Lally A, Casabonne D, Newton R, Wojnarowska F. Seborrheic dermatitis among oxford renal transplant recipients1. J Eur Acad Dermatol 2010;24:561-564 https://doi.org/10.1111/j.1468-3083.2009.03470.x
  7. Gupta AK, Kohli Y, Li A, Faergemann J, Summerbell RC. In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine. Br J Dermatol 2000;142:758-765 https://doi.org/10.1046/j.1365-2133.2000.03294.x
  8. Leeming JP, Notman FH. Improved methods for isolation and enumeration of Malassezia furfur from human skin. J Clin Microbiol 1987;25:2017-2019
  9. Sugita T, Tajima M, Ito T, Saito M, Tsuboi R, Nishikawa A. Antifungal activities of tacrolimus and azole agents against the eleven currently accepted Malassezia species. J Clin Microbiol 2005;43:2824-2829 https://doi.org/10.1128/JCM.43.6.2824-2829.2005
  10. Rojas FD, Cordoba SB, de Los Angeles Sosa M, Zalazar LC, Fernandez MS, Cattana ME, et al. Antifungal susceptibility testing of Malassezia yeast: comparison of two different methodologies. Mycoses 2017;60:104-111 https://doi.org/10.1111/myc.12556
  11. Crespo Erchiga V, Ojeda Martos AA, Vera Casano A, Crespo Erchiga A, Sanchez Fajardo F. [Isolation and identification of Malassezia spp. In pytiriasis versicolor, seborrheic dermatitis and healthy skin.]. Rev Iberoam Micol 1999;16:S16-21
  12. Lee YW, Yim SM, Lim SH, Choe YB, Ahn KJ. Quantitative investigation on the distribution of Malassezia species on healthy human skin in Korea. Mycoses 2006;49:405-410 https://doi.org/10.1111/j.1439-0507.2006.01239.x
  13. Prohic A, Simic D, Sadikovic TJ, Krupalija-Fazlic M. Distribution of Malassezia species on healthy human skin in Bosnia and Herzegovina: correlation with body part, age and gender. Iran J Microbiol 2014;6:253-262
  14. Lee YW, Lim SH, Ahn KJ. The application of 26 rDNA PCR-RFLP in the identification and classification of Malassezia yeast. Korean Journal of Medical Mycology 2006;11:141-153
  15. Song YC, Yim SH, Jung BR, Lee YW, Choe YB, Ahn KJ. The application of pyrosequencing method in the identification and classification of Malassezia yeasts. Korean Journal of Medical Mycology 2007;12:189-197
  16. Yim SM, Kim JY, Ko JH, Lee YW, Choe YB, Ahn KJ. Molecular analysis of Malassezia microflora on the skin of the patients with atopic dermatitis. Annals of Dermaology 2010;22:41-47 https://doi.org/10.5021/ad.2010.22.1.41
  17. Oh BH, Lee YW, Choe YB, Ahn KJ. Epidermiologic study of Malassezia yeast in seborrheic dermatitis patients by the analysis of 26s rDNA PCR-RFLP. Annals of Dermaology 2010;22:149-155 https://doi.org/10.5021/ad.2010.22.2.149
  18. Song YC, Hahn HJ, Kim JY, Ko JH, Lee YW, Choe YB. Epidemiologic study of Malassezia yeasts in acne patients by analysis of 26s rDNA PCR-RFLP. Annals of Dermaology 2011;23:321-328 https://doi.org/10.5021/ad.2011.23.3.321
  19. Kim SY, Kim SH, Kim SN, Kim AR, Kim YR, Kim MJ, et al. Isolation and identification of Malassezia species from Chinese and Korean patients with seborrheic dermatitis and in vitro studies on their bioactivity on sebaceous lipids and IL-8 production. Mycoses 2016;59:274-280 https://doi.org/10.1111/myc.12456
  20. Aspiroz C, Ara M, Varea M, Rezusta A, Rubio C. Isolation of Malassezia globosa and M. sympodialis from patients with pityriasis versicolor in Spain. Mycopathologia 2002;154:111-117 https://doi.org/10.1023/A:1016020209891
  21. Juntachai W, Oura T, Murayama SY, Kajiwara S. The lipolytic enzymes activities of Malassezia species. Med Mycol 2009;47:477-484 https://doi.org/10.1080/13693780802314825
  22. Pilgram GS, Vissers DC, van der Meulen H, Pavel S, Lavrijsen SP, Bouwstra JA, et al. Aberrant lipid organization in stratum corneum of patients with atopic dermatitis and lamellar ichthyosis. J Invest Dermatol 2001;117:710-717 https://doi.org/10.1046/j.0022-202x.2001.01455.x
  23. Gupta AK, Kohli Y, Summerbell RC, Faergemann J. Quantitative culture of Malassezia species from different body sites of individuals with or without dermatoses. Med Mycol 2001;39:243-251 https://doi.org/10.1080/mmy.39.3.243.251
  24. Park HJ, Lee YW, Choe YB, Ahn KJ. Skin characteristics in patients with pityriasis versicolor using non-invasive method, MPA5. Annals of Dermaology 2012;24:444-452 https://doi.org/10.5021/ad.2012.24.4.444
  25. Bueno JG, Martinez C, Zapata B, Sanclemente G, Gallego M, Mesa AC. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis. Clin Exp Dermatol 2010;35:658-663
  26. Van Duyn Graham L, Elewski BE. Recent updates in oral terbinafine: its use in onychomycosis and tinea capitis in the US. Mycoses 2011;54:e679-685 https://doi.org/10.1111/j.1439-0507.2011.02038.x
  27. Lee YW, Kim SM, Oh BH, Lim SH, Choe YB, Ahn KJ. Isolation of 19 strains of Malassezia dermatis from healthy human skin in Korea. J Dermatol 2008;35:772-777 https://doi.org/10.1111/j.1346-8138.2008.00567.x
  28. Garau M, Pereiro M, Jr., del Palacio A. In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds. Antimicrob Agents Chemother 2003;47:2342-2344 https://doi.org/10.1128/AAC.47.7.2342-2344.2003
  29. Schmidt A, Ruhl-Horster B. In vitro susceptibility of Malassezia furfur against azole compounds. Mycoses 1996;39:309-312 https://doi.org/10.1111/j.1439-0507.1996.tb00145.x
  30. Cafarchia C, Figueredo LA, Iatta R, Colao V, Montagna MT, Otranto D. In vitro evaluation of Malassezia pachydermatis susceptibility to azole compounds using E-test and CLSI microdilution methods. Med Mycol 2012;50:795-801 https://doi.org/10.3109/13693786.2012.674219
  31. Das J, Majumdar M, Chakraborty U, Majumdar V, Mazumdar G, Nath J. Oral itraconazole for the treatment of severe seborrhoeic dermatitis. Indian J Dermatol 2011;56:515-516 https://doi.org/10.4103/0019-5154.87137
  32. Zhang YY, Zhou X, National Collaborative Group of Sequential Itraconazole Treatment for Invasive Pulmonary Mycosis. Efficacy and safety of intravenous itraconazole followed by oral itraconazole solution in the treatment of invasive pulmonary mycosis. Chin Med J (Engl) 2011;124:3415-3419
  33. Gupta AK, Paquet M. Improved efficacy in onychomycosis therapy. Clin Dermatol 2013;31:555-563 https://doi.org/10.1016/j.clindermatol.2013.06.010
  34. Leeming JP, Sansom JE, Burton JL. Susceptibility of Malassezia furfur subgroups to terbinafine. Br J Dermatol 1997;137:764-767 https://doi.org/10.1111/j.1365-2133.1997.tb01115.x